维普期刊资源整合服务平台（V6.5）

49篇 您的检索式：作者名="Remick S"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Role of interleukin-6 in mortality from and physiologic response to sepsis显示文摘	Remick D G Bolgos G Copeland S	2005	Infect Immun2005，73，：	1
2	Sepsis:redox mechanisms and therapeutic opportunities显示文摘	Biswal S Remick D G		0，，11：	1
3	Role of interleukin-6 in mortality from and physiologic response to sepsis 显示文摘	Remick D G Bolgos G Copeland S	2005	Infect Immun2005，73，5：	1
4	A dose-escalating and pharmacologic study of bortezomib in adult cancer patients with impaired renal function 显示文摘	Mulkerin D Remick S Ramanathan R	2006	J Clin Oncol2006，24，18：	1
5	Require- ments for tumor necrosis factor-alpha and interleukin-1 in limb ischemia/reperfision injury and associated lung inju- ry显示文摘	Seekamp A Warren J S Remick K G	1993	Am J Pathol1993，143，2：	1
6	Exogenous interleu- kin - 10 fails to decrease the mortality or morbidity of sepsis 显示文摘	Remick DG Garg S J Newcomb DE	1998	Crlt Care Med1998，26，5：	1
7	Role of interleukin-6 in mortality from and physiologic response to sepsis显示文摘	Remick DG Bolgos G Copeland S	2005	Infect Immun2005，73，5：	1
8	Combination immunotherapy with soluble tumor necrosis factor receptors plus interleukin 1 receptor antagonist decreases sepsis mortality显示文摘	REMICK D G CALL D R EBONG S J	2001	Crit Care Med2001，29，3：	1
9	Requirements for tumor necrosis factor-a and interleukin-1 in limb ischemia/reperfusion injury and associated lung injury显示文摘	Seekamp A Warren J S Remick D G et a1	1993	Am J Pathol1993，143，：	1
10	Role of tumor necrosis factor-α in the pathophysiologic alternationsafter hepatic ischemia/reperfusion injury in the rat显示文摘	Colletti L M Remick D G Kunkel S L		0，，：	1
11	Combination immunotherapy with soluble tumor necrosis factor receptors plus interleukin 1 receptor antagonist decreases sepsis mortality 显示文摘	Remick DG Call DR Ebong S J	2001	Crit Care Med2001，29，3：	1
12	Albumin depletion of human plasma also removes low abundance protein including the cytokines 显示文摘	Granger J SJ Copeland S Remick D	2005	Proteomics2005，5，18：	1
13	The pathogenesis of sepsis 显示文摘	Stearns-Kurosawa D J Osuchowski M F Valentine C Kurosawa S Remick D G	2011	Annu Rev Pathol2011，6，：	1
14	Extrapulmonary and pulmonary small-cell carcinoma:tumor biology,therapy and outcome显示文摘	Remick S C Ruckdeschel J C	1992	Med Pediatr Oncol1992，20，2：	1
15	Combination im-munotherapy with soluble tumor nectosis factor receptors plus interleukin-1 receptor antagonist decreases sepsis mortality显示文摘	REMICK D G CALL D R EBONG S J	2001	Crit CareMed2001，110，1：	1
16	Combination immunotherapy with soluble tumor nectosis factor receptors plus interleukin-1 receptor antagonist decreases sepsis mortality显示文摘	REMICK D G CALL D R EBONG S J	2001	Crit Care Med2001，29，3：	1
17	Intratracheal administration of endotoxin and cytokines: Ⅷ LPS induces E-selectin expressions anti-E-seleetin and soluble E-seleetin inhibit acute inflammation显示文摘	Ulich T R Howard S C Remick D G	1994	Inflammation1994，18，4：	1
18	Role of interleukin - 6 in mortality from and physiologic response to sepsis显示文摘	Remick DG Bolgos G Copeland S	2005	Infect Immun2005，73，5：	1
19	Acute pulmonary lipopolysaccharide tolerance decreases TNF - α without reducing neutro- phil recruitment 显示文摘	Natarajan S Kim J Remick D G	2008	J Immunol2008，181，12：	1
20	Sepsis:redox mechanisms and therapeutic opportunities显示文摘	Biswal S Remick D G	2007	Antioxid Redox Signal2007，9，11：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示